Navigation Links
North East Having Highest Cancer Incidences In Country

Certain pockets of the North Eastern region have the highest cancer incidences rate compared to that of the rest of the country, a study done by the National Cancer Registry Programme (NCRP) has shown.//

Mizoram capital Aizawl has the maximum number of tongue cancer surpassing the figure of Bhopal which had witnessed a horrible gas tragedy over two decades ago, Dr A Nandkumar, NCRP officer in-charge told a medical conference here today.

Nagaland and Manipur showed the highest age adjusted incidence rate for nasopharyngeal cancers.

For cancer of tonsil, Darrang, Kamrup, Dibrugarh, Barpeta and Nalbari districts of Assam have the highest incidences. These districts also topped the list of oropharyngeal cancers, the doctor, also the deputy director general of the Indian Council of Medical Research, said in his presentation.

However, no figures were given.

Men of Mizoram and Assam and women of Meghalaya and Assam have the highest number of cancer of esophagus while on cancer of stomach, Mizoram, Nagaland and Sikkim are on the high.

He said China and Hong Kong topped the list of cancer of nasopharynx in the world but some Nagaland districts bordering Myanmar surpassed that record also.

Because of smoking, lung cancer among the women was on the rise in western countries but the study showed that incidences of this type of disease were even higher in women of Manipur and Mizoram who also have smoking habit.

When it comes to age adjusted incidence rates of other common types like cancer of uterine cervix and breast (for female), the North Eastern states were not far behind. Mizoram ranked third in the country in these types.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Northfield Labs Receives FDA Comments
2. Brain Fever or Encephalitis Spreading in North India
3. Kids In Northern India To Be Vaccinated Against Encephalitis
4. Northeast To Get Mega Rural Health Mission
5. North-Eastern Leaders Of India Meet To Discuss HIV Problems
6. New outbreak of birdflu reported in Northern China
7. Move to make HIV Tests mandatory For Soldiers In Northeast
8. Rise In Obesity Among North Qeenslanders
9. Northeast Governments Warn Against Andhra Fish
10. The mystery of the bulge in North Queenslanders
11. Bird Flu Reported In Northern Iraq
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 2Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 3Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 4Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 5Health News:Regenerus Life Enhancement Programme from The Diagnostic Clinic Will Take the Fear Out of Ageing 6Health News:Buffalo Personal Injury Lawyers Cellino & Barnes Donate $1M to UB School of Law, Appear on Cover of School's Philanthropy Magazine 2Health News:Wellness Manufacturer Wins Two 2009 American Spa Awards 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 2Health News:The Flag Company, Inc.'s Recently Released “Feel Good” Light Lenses Grows Into Its Own Website 3Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2
Breaking Medicine Technology:ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Mathematical modeling predicts response to Herceptin 52980 1Mathematical modeling predicts response to Herceptin 52980 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 1Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 2Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 3Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer 52979 4The CLASS Act 3A Retirement In Security 52977 1The CLASS Act 3A Retirement In Security 52977 2